36C25525Q0035.pdf

Combined Synopsis/Solicitation Notice

*= Required Field Combined Synopsis/Solicitation Notice

SUBJECT* Cost-Per-Test Clinical Laboratory Analyzers

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 66048

SOLICITATION NUMBER* 36C25525Q0035

RESPONSE DATE/TIME/ZONE 10-29-2024 5PM CENTRAL TIME, CHICAGO, USA

ARCHIVE 10 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

SET-ASIDE

PRODUCT SERVICE CODE* 6550

NAICS CODE* 325413

CONTRACTING OFFICE ADDRESS Department of Veterans Affairs

Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway

Leavenworth KS 66048

POINT OF CONTACT*

Contracting Officer Mickeya Linzie mickeya.linzie@va.gov

PLACE OF PERFORMANCE

ADDRESS Kansas City VA Medical Center St. Louis VA Medical Center Columbia (MO) VA Medical Center

POSTAL CODE

COUNTRY USA

ADDITIONAL INFORMATION

AGENCY’S URL https://www.va.gov/ URL DESCRIPTION Department of Veterans Affairs AGENCY CONTACT’S EMAIL ADDRESS mickeya.linzie@va.gov EMAIL DESCRIPTION Mickeya Linzie | Contracting Officer

DESCRIPTION

This solicitation is to establish a Blanket Purchase Agreement (BPA) for Cost-Per-Test Clinical Laboratory Analyzers.

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C25525Q0035 10-22-2024

Linzie, Mickeya | mickeya.linzie@va.gov (913) 946-1967 10-29-2024

5PM CDT

36C255 Department of Veterans Affairs Network Contracting Office (NCO) 15

X

325413

1250 Employees

Net 30

N/A

X

Kansas City VA Medical Center

36C255

Department of Veterans Affairs Network Contracting Office (NCO) 15

36C255

Financial Services Center http://www.fsc.va.gov/einvoice.asp

Austin TX

877-353-9791 512-460-5429

See CONTINUATION Page

This solicitation is to establish a Blanket Purchase Agreement (BPA) for Cost-Per-Test Clinical Laboratory Analyzers for the following VISN 15 VA facilities:

1. Kansas City VA Medical Center, 4801 Linwood Blvd, Kansas City, MO 64128

2. St. Louis VA Medical Center, 915 N Grand Blvd, St. Louis, MO, 63106

3. Columbia (MO) VA Medical Center, 800 Hospital Drive, Columbia, MO 65201

Submit questions to mickeya.linzie@va.gov no later than 10/25/2024. All questions will be consolidated and an amendment with answers will be posted on sam.gov no later than 10/26/2024.

See CONTINUATION Page

X X

X 1

MICKEYA LINZIE

CONTRACTING OFFICER

36C25525Q0035

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 PRICE/COST SCHEDULE

ITEM INFORMATION

B.2 DELIVERY SCHEDULE

B.3 TERMS AND CONDITIONS

B.4 ADMINISTRATIVE DATA

B.5 PRICING DATA

B.6 OPTION TO EXTEND THE TERM OF THE BPA

B.7 GENERAL SUPPLY ORDERS

B.8 AUTHORIZED LIMITS

B.9 OBLIGATION OF FUNDS

B.10 PERIOD OF PERFORMANCE

B.11 AUTHORIZED INDIVIDUALS

B.12 ORDER FORMAT

B.13 AUTHORIZED REPRESENTATIVES

B.14 FEDERAL HOLIDAYS

B.15 MANAGEMENT CONTROL

B.16 INVOICES

B.17 PRECEDENCE

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (NOV 2023)

C.2 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000) ...47

C.4 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.5 VAAR 852.208-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTORS – ORDERS or BPAs (JAN

2023) (DEVIATION)

C.6 VAAR 852.208-71 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTOR COMMITMENTS-ORDERS AND

BPAS (JAN 2023) (DEVIATION)

C.7 VAAR 852.211-70 EQUIPMENT OPERATION AND MAINTENANCE MANUALS

(NOV 2018)

C.8 VAAR 852.212-71 GRAY MARKET AND COUNTERFEIT ITEMS (FEB 2023)

C.9 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV

2018)

C.10 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) ..51

C.11 VAAR 852.246-71 REJECTED GOODS (OCT 2018)

C.12 VAAR 852.247-71 DELIVERY LOCATION (OCT 2018)

C.13 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAY 2024)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.201-1 ACQUISITION 360: VOLUNTARY SURVEY (SEP 2023)

E.2 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (SEP 2023)

E.3 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.4 52.214-21 DESCRIPTIVE LITERATURE (APR 2002) ALTERNATE I (JAN 2017) .66

E.5 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.6 52.204-29 FEDERAL ACQUISITION SUPPLY CHAIN SECURITY ACT

ORDERS—REPRESENTATION AND DISCLOSURES (DEC 2023)

E.7 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.8 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.9 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)

E.10 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE

RESOLUTION (OCT 2018)

E.11 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.12 VAAR 852.239-75 INFORMATION AND COMMUNICATION TECHNOLOGY

ACCESSIBILITY NOTICE (FEB 2023)

E.13 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.14 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAY 2024)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT

UNIT

PRICE AMOUNT

Kansas City VA Medical Center - Cost-Per-Test Clinical Laboratory Analyzers Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

0001A

1.00 UN ________ ________

Erytra Eflexis Service

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001B

72.00 UN ________ ________

DG GEL 8 A/B/D X2 (50 CARDS)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001C

12.00 UN ________ ________

DG GEL 8 AB (x4) (50 CARDS)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001D

24.00 UN ________ ________

DG GEL 8 NEUTRAL (50 CARDS)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

0001E

DG GEL 8 ANTI-IgG (50 CARDS)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001F

GRIFOLS DILUENT (2 X 100 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001G

GRIFOLS WASH SOL A

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001H

GRIFOLS WASH SOL B

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001I

60.00 UN ________ ________

DG GEL EXTENDED CONTROL (4 X 6 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001J

120.00 UN ________ ________

SEARCH-CYTE TCS 0.8% (3 X 10 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025

Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

0001K

DATA-CYTE PLUS 0.8% (11 X 4 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001L

REVERSE-CYTE A1,B 0.8% (3 X 10 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0001M

13.00 UN ________ ________

DATA-CYTE PLUS 2 0.8% (11 X 4 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

St. Louis VA Medical Center - Cost-Per-Test Clinical

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002A

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002B

117.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024

POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

0002C

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002D

65.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002E

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002F

25.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002G

10.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002H

19.00 UN ________ ________

Contract Period: BASE

POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

0002I

52.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002J

142.00 UN ________ ________

SEARCH-CYTE PLUS 0.8% (2 X 10 mL)

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002K

0.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002L

26.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002M

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0002N

DATA-CYTE PLUS 2 0.8% (11 X 4 mL) Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Columbia (MO) VA Medical Center - Cost-Per-Test Clinical

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0003A

2.00 UN ________ ________

SPIN, THERM and PIPETTES

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0003B

30.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0003C

8.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0003D

28.00 UN ________ ________

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

0003E

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0003F

20.00 UN ________ ________

PIPETTE TIPS

Contract Period: BASE POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001A

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001B

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001C

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

1001D

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001E

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001F

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001G

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001H

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001I

Contract Period: OPTION ONE

POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

1001J

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001K

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001L

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1001M

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002A

Erytra Eflexis Service Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002B

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002C

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002D

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002E

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002F

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002G

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002H

19.00 UN ________ _______

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002I

52.00 UN ________ _______________

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002J

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002K

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002L

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

1002M

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1002N

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1003A

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1003B

30.00 UN ________ _______

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1003C

Contract Period: OPTION ONE

POP End: 10-31-2026

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

1003D

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1003E

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1003F

Contract Period: OPTION ONE POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001A

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001B

Contract Period: OPTION TWO

POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

2001C

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001D

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001E

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001F

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001G

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001H

GRIFOLS WASH SOL B

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001I

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001J

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001K

12.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001L

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2001M

13.00 UN ______ _______

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002A

1.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002B

117.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002C

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002D

65.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002E

65.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

2002F

25.00 UN _______ _______

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002G

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002H

19.00 UN _______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002I

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002J

142.00 UN _______ ______

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002K

0.00 UN ______ ________

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027

Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

2002L

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002M

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2002N

13.00 UN ________ _______

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003A

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003B

Contract Period: OPTION TWO POP Begin: 11-01-2026

POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003C

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003D

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003E

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2003F

Contract Period: OPTION TWO POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001A

Erytra Eflexis Service Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001B

72.00 UN _______ ______

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001C

12.00 UN _______ _______

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001D

24.00 UN _______ ______

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001E

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001F

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001G

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001H

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001I

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001J

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001K

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3001L

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

3001M

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002A

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002B

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002C

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002D

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

3002E

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002F

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002G

10.00 UN _______ _______

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002H

19.00 UN ________ ________

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002I

52.00 UN _______ ________

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002J

Contract Period: OPTION THREE POP Begin: 11-01-2027

POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002K

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002L

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002M

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3002N

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003A

SPIN, THERM and PIPETTES Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003B

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003C

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003D

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003E

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

3003F

Contract Period: OPTION THREE POP Begin: 11-01-2027 POP End: 10-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001A

1.00 UN ________ _______

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001B

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001C

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001D

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001E

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

4001F

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001G

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001H

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001I

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001J

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001K

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029

Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

4001L

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4001M

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002A

1.00 UN ______ ________

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002B

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002C

Contract Period: OPTION FOUR POP Begin: 11-01-2028

POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002D

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002E

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002F

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002G

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002H

19.00 UN ________ _______

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002I

DG GEL EXTENDED CONTROL (4 X 6 mL) Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002J

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002K

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002L

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002M

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002N

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4003A

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4003B

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4003C

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4003D

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4003E

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

4003F

Contract Period: OPTION FOUR POP Begin: 11-01-2028 POP End: 10-31-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

GRAND

TOTAL

B.2 DELIVERY SCHEDULE

ITEM

NUMBER SHIPPING INFORMATION QUANTITY

DELIVERY

DATE

0001 SHIP TO: Kansas City VA Medical Center 4801 Linwood Boulevard Kansas City, MO 64128

USA

ALL Per VA Facility Requirements

FOB: DESTINATION

0002 SHIP TO: St. Louis VA Medical Center 915 North Grand Boulevard St. Louis, MO 63106

USA

ALL Per VA Facility's

0003 SHIP TO: Columbia (MO) VA Medical Center 800 Hospital Dr Columbia, MO 65201

USA

ALL Per VA Facility's

B.3 TERMS AND CONDITIONS

The Contractor agrees to the following terms of a Blanket Purchase Agreement (BPA) EXCLUSIVELY WITH the Department of Veterans Affairs:

B.4 ADMINISTRATIVE DATA

A Blanket Purchase Agreement (BPA) is hereby established between and the Department of Veterans Affairs under the following terms and conditions incorporated in this BPA:

Primary Point of Contact: TBD

Alternate Point of Contact:

DUNS NUMBER:

Cognizant Office (Include complete address):

Network Contracting Office (NCO) 15

B.5 PRICING DATA

1. The prices included on the BPA list (or applicable "discounted" rates submitted in a proposal response to an RFQ resulting in award) that are in effect on the effective date of an order shall govern that order's basic performance period. With regard to any option years, which are later exercised, the proposed option year rates as incorporated into the order award are in effect until such time, if applicable, that the contractor has been authorized a rate increase culminating from a negotiation with the Contracting Officer.

2. The BPA holder can voluntarily reduce offered prices at any time by giving 24-hour advance notice (by facsimile or electronic-mail) to the Department of Veterans Affairs/Contracting Officer.

This BPA also allows for additional discounts if a "large order" is placed at one time. An advanced notice is not required for discounts offered for only an individual order. Whether an order is large enough to warrant such a discount is subject to the discretion of the BPA holder.

3. The BPA holder may also increase BPA prices at any time. Any BPA price increase shall not take effect until the Department of Veterans Affairs Contracting Officer receives written notification (U.S. mail, facsimile, or electronic-mail). Any order already issued shall not be affected by any change to BPA pricing. The prices offered under this BPA will undergo annual review by the Department of Veterans Affairs Contracting Officer.

B.6 OPTION TO EXTEND THE TERM OF THE BPA

a. The Government may extend the term of this BPA by written notice to the Contractor at any time prior to the expiration of the BPA, provided that the Government shall give the Contractor a preliminary written notice of its intent to extend at least 10 days before the BPA expires. The preliminary notice does not commit the Government to an extension.

b. If the Government exercises this option, the extended BPA shall be considered to include this option provision.

B.7 GENERAL SUPPLY ORDERS

A properly appointed Department of Veterans Affairs Contracting Officer will request a quote from the Contractor based upon the requirements of the individual calls/orders, usually in the form of a Statement of Work (SOW). The information provided to the Contractor will include the place of performance, required period of performance, and other particular task requirements.

Travel may be required (reimbursement of travel expenses will be IAW applicable Federal travel regulations). The vendor will reply within 3 business days with a quote depending on the details required by the SOW. The Contractor may offer additional spot discounts on any order, as they deem appropriate. All subcontractor activity must be clearly identified in each new order proposal as applicable.

B.8 AUTHORIZED LIMITS

The Government estimates, but does not guarantee, that individual BPA Orders placed against this Agreement may reach $300,000.00/per Order. This Order Limit may be increased by mutual agreement of the parties as necessary, in whole or part. The authorized Ceiling Limit of the Agreement is set at $1,500,000.00 over the period covered by the Agreement; this ceiling is also not a guarantee. The Ceiling Limit may also be raised in association with Order Limit increases or other conditions which, by mutual agreement of the parties, maybe considered necessary. Authorization for individual orders above the stated order and/or Ceiling Limits must be coordinated through the Contracting Officer before larger valued orders can be issued and prior to commencement of work. All unauthorized work, regardless of amount, will be processed through the ratification process.

B.9 OBLIGATION OF FUNDS

This BPA does not obligate any funds. The Government is obligated only to the extent of authorized orders actually issued under the BPA by the Contracting Officer.

B.10 PERIOD OF PERFORMANCE

This BPA expires on 10-31-2029 or such later ending date as determined by the exercise of any option.

B.11 AUTHORIZED INDIVIDUALS

Individuals Authorized to Place Orders:

DVA authorizes the following entities to place orders:

Kansas City VA Medical Center

B.12 ORDER FORMAT

Orders will be placed against this BPA via e-mail, Electronic Data Interchange (EDI), FAX, or in hardcopy format. Each individual BPA Order will describe the tasks, services and deliverables required.

B.13 AUTHORIZED REPRESENTATIVES

The primary Contracting Officer (CO) for this Agreement is:

MICKEYA LINZIE

Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway Leavenworth, KS 66048 mickeya.linzie@va.gov

The Primary Contracting Officer's Representative (COR) for projects under this Agreement is:

ZAIDA RIVERA

(816) 861-4700 ext 56185 zaida.rivera@va.gov mailto:mickeya.linzie@va.gov mailto:zaida.rivera@va.gov

The Secondary Contracting Officer's Representative (COR) for projects under this Agreement is:

The Primary and/or Secondary COR will be responsible for technical monitoring of the contractor's performance and deliveries. The COR and the Contractor's Representative shall work together to ensure that all contractual requirements are being met. The COR will interpret specifications or technical portions of the work. The COR is not authorized to perform, formally or informally, any of the following actions:

(1) Promise, award, agree to award, or execute any contract, contract modification, or notice of intent that changes or may change this contract;

(2) Waive or agree to modification of the delivery schedule;

(3) Make any final decision on any contract matter subject to the Disputes Clause;

(4) Terminate, for any reason, the contractor's right to proceed;

(5) Obligate in any way, the payment of money by the Government. Only a warranted Contracting Officer is authorized to obligate funds on this or any other contract action.

The contractor shall immediately notify the Contracting Officer in writing if the COR has taken an action (or fails to take action) or issues directions (written or oral) that the contractor considers to exceed the above limitations.

The contractor shall provide the Contracting Officer information copies of all correspondence to the COR.

B.14 FEDERAL HOLIDAYS

Unless specifically authorized in writing by the Contracting Officer, no services will be provided and no charges will be incurred and/or billed to any order on this contract on any of the Federal Holidays listed below.

New Year’s Day Labor Day Birthday of Martin Luther King, Jr. Columbus Day Washington’s Birthday Veterans' Day Memorial Day Thanksgiving Day Juneteenth Christmas Day Independence Day

B.15 MANAGEMENT CONTROL

The BPA holder shall provide to the Contracting Officer (CO) a list of all teaming partners or subcontractors within 30 calendar days after order award. As subcontractors and/or teaming partners are added, and/or deleted, an updated listing will be provided to the CO within 30 calendar days of such change. All BPA holder personnel shall display identification badges at all times while charging hours to the order or at a government or government contractor location. Authorized Government personnel shall accompany all visits to Department of Veterans Affairs Program Offices, unless other specific arrangements have been made.

B.16 INVOICES

a. Inspection and acceptance shall be accomplished as follows: The Government, for all services furnished under any resulting order, hereby designates the COR in the program office as the point of final inspection and acceptance. The BPA holder will submit each invoice, including all back-up data, to the Contracting Officer (CO) for review and signature. When the CO receives an accurate and complete invoice, he/she will return a signed copy to the BPA holder within five (5) working days. If the invoice is incomplete or inaccurate, the CO will return the unsigned invoice to the BPA holder for correction. The Contracting Officer will then forward the signed invoice to the Chief Financial Officer (CFO) for payment. Final payment for each order will be accomplished by final invoice accompanied by a receiving report.

b. An itemized invoice shall be submitted to the CO at least monthly or upon expiration of this BPA, whichever occurs first, for all deliveries made during a billing period and for which payment has not been received. Copies of delivery tickets shall support these invoices.

"Approved-for-payment" invoices will be submitted to the payment address specified on each individual order issued under this BPA.

B.17 PRECEDENCE

The Terms and conditions included in this BPA apply to all purchases made pursuant to it. In the event of an inconsistency between the provisions of this BPA and the Contractor's invoice, the provisions of this BPA will take precedence.

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (NOV 2023)

(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered;

and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.

(g) Invoice.

(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—

(i) Name and address of the Contractor;

(ii) Invoice date and number;

(iii) Contract number, line item number and, if applicable, the order number;

(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;

(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;

(vi) Terms of any discount for prompt payment offered;

(vii) Name and address of official to whom payment is to be sent;

(viii) Name, title, and phone number of person to notify in event of defective invoice; and

(ix) Taxpayer Identification Number (TIN).